Legal Opinion
Astrazeneca Pharmaceuticals, LP v. Mayne Pharma (USA), Inc.
District Court, S.D. New York
Decided December 28, 2004No. 02 Civ.7936(WHP), 03 Civ.6487(WHP)PublishedCited by 3 opinions
1Opinion of the Court
MEMORANDUM AND ORDER■
PAULEY, District Judge.
AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd. (collectively, “Plaintiffs” or “AstraZeneca”) allege patent infringement by Mayne Pharma (USA) Inc. (“Defendant” or “Mayne”), formerly known as Faulding Pharmaceutical Company. In particular, AstraZeneca accuses Mayne of infringing U.S. Patent Nos. 5,714,520 (the “ ’520 patent”), 5,731,355 and 5,731,356 (collectively, the “asserted patents”) by filing the Abbreviated New Drug Application (“ANDA”) No. 76-452 with the Food and Drug Administration (“FDA”).
This Court conducted a Markman hearing to…
2Cases cited42 opinions
- MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
- Vitronics Corporation v. Conceptronic, Inc.Court of Appeals for the Federal Circuit · 1996
- Cybor Corporation v. Fas Technologies, Inc., and Fastar Ltd., Defendants-CrossCourt of Appeals for the Federal Circuit · 1998
- Sri International v. Matsushita Electric Corporation of America and Matsushita Electric Industrial Co., Ltd.Court of Appeals for the Federal Circuit · 1985
- Renishaw Plc v. Marposs Societa' Per Azioni and Marposs CorporationCourt of Appeals for the Federal Circuit · 1998
37 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- Abraxis Bioscience, Inc. v. Mayne Pharma (USA) Inc.Court of Appeals for the Federal Circuit · 2006
- McNeil-PPC, Inc. v. Perrigo Co.District Court, S.D. New York · 2006
- EBS Dealing Resources, Inc. v. Intercontinental Exchange, Inc.District Court, S.D. New York · 2005